Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid
Go back to Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid| National Health Partners, Inc. (NYSE: HPR) | Delayed: 4.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.73 | 52 Week High | $0.28 | |||
| Open | $3.62 | 52 Week Low | $0.25 | |||
| Day High | $4.73 | P/E | N/A | |||
| Day Low | $4.73 | EPS | $-0.23 | |||
| Volume | 3,248 | |||||
| HORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.30 | 52 Week High | $23.44 | |||
| Open | $19.84 | 52 Week Low | $13.06 | |||
| Day High | $116.30 | P/E | N/A | |||
| Day Low | $116.30 | EPS | $-0.96 | |||
| Volume | 283,408 | |||||
